• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿霉素在组织中的蓄积及其对心脏、平滑肌和骨骼肌功能的影响。

Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle function.

机构信息

School of Sport and Exercise Science, University of Northern Colorado, Greeley, CO 80639, USA.

出版信息

J Physiol Biochem. 2013 Jun;69(2):177-87. doi: 10.1007/s13105-012-0200-0. Epub 2012 Aug 14.

DOI:10.1007/s13105-012-0200-0
PMID:22890792
Abstract

Cancer-related fatigue is a pervasive syndrome experienced by a majority of cancer patients undergoing treatment, and muscular dysfunction may be a key component in the development and progression of this syndrome. Doxorubicin (DOX) is a commonly used antineoplastic agent used in the treatment of many cancers. The purpose of this study was to determine the effect of DOX exposure on the function of cardiac, skeletal, and smooth muscle tissues and examine the role accumulation of DOX may play in this process. In these studies, rats were treated with DOX and measurements of cardiac, skeletal, and smooth muscle function were assessed 1, 3, and 5 days after exposure. All muscular tissues showed significant and severe dysfunction, yet there was heterogeneity both in the time course of dysfunction and in the accumulation of DOX. Cardiac and skeletal muscle exhibited a time-dependent progressive decline in function during the 5 days following DOX treatment. In contrast, vascular function showed a decline in function that could be characterized as rapid onset and was sustained for the duration of the 5-day observation period. DOX accumulation was greatest in cardiac tissue, yet all muscular tissues showed a similar degree of dysfunction. Our data suggest that in muscular tissues both DOX-dependent and DOX-independent mechanisms may be involved with the muscular dysfunction observed following DOX treatment. Furthermore, this study highlights the fact that dysfunction of skeletal and smooth muscle may be an underappreciated aspect of DOX toxicity and may be a key component of cancer-related fatigue in these patients.

摘要

癌症相关性疲劳是大多数接受治疗的癌症患者普遍经历的一种综合征,肌肉功能障碍可能是该综合征发展和进展的关键组成部分。阿霉素(DOX)是一种常用于治疗多种癌症的常用抗肿瘤药物。本研究旨在确定 DOX 暴露对心脏、骨骼和平滑肌组织功能的影响,并探讨 DOX 积累在这一过程中可能发挥的作用。在这些研究中,大鼠接受 DOX 治疗,并在暴露后 1、3 和 5 天评估心脏、骨骼和平滑肌功能的测量值。所有肌肉组织均表现出明显且严重的功能障碍,但在功能障碍的时间过程和 DOX 的积累方面存在异质性。心脏和骨骼肌在 DOX 治疗后 5 天内表现出功能的时间依赖性进行性下降。相比之下,血管功能表现出快速发作和持续 5 天观察期的功能下降。DOX 在心脏组织中的积累最大,但所有肌肉组织均表现出相似程度的功能障碍。我们的数据表明,在肌肉组织中,DOX 依赖性和 DOX 非依赖性机制可能都与 DOX 治疗后观察到的肌肉功能障碍有关。此外,本研究强调了这样一个事实,即骨骼和平滑肌功能障碍可能是 DOX 毒性被低估的一个方面,并且可能是这些患者癌症相关性疲劳的关键组成部分。

相似文献

1
Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle function.阿霉素在组织中的蓄积及其对心脏、平滑肌和骨骼肌功能的影响。
J Physiol Biochem. 2013 Jun;69(2):177-87. doi: 10.1007/s13105-012-0200-0. Epub 2012 Aug 14.
2
Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy.阿霉素诱导的心肌和骨骼肌病变需要增加线粒体活性氧的释放以及钙蛋白酶的激活。
J Physiol. 2015 Apr 15;593(8):2017-36. doi: 10.1113/jphysiol.2014.286518. Epub 2015 Feb 23.
3
Effects of age on multidrug resistance protein expression and doxorubicin accumulation in cardiac and skeletal muscle.年龄对心肌和骨骼肌中多药耐药蛋白表达及阿霉素蓄积的影响。
Xenobiotica. 2014 May;44(5):472-9. doi: 10.3109/00498254.2013.846489. Epub 2013 Oct 18.
4
Exercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle.运动可预防阿霉素诱导的骨骼肌氧化应激和蛋白水解。
J Appl Physiol (1985). 2011 Apr;110(4):935-42. doi: 10.1152/japplphysiol.00677.2010. Epub 2011 Feb 10.
5
Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle.多柔比星导致严重的高血糖和胰岛素抵抗,这是通过抑制骨骼肌中的 AMPk 信号传导介导的。
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):615-625. doi: 10.1002/jcsm.12104. Epub 2016 Feb 15.
6
Doxorubicin chemotherapy affects intracellular and interstitial nitric oxide concentrations in skeletal muscle : Effect of doxorubicin on intracellular and interstitial NO in skeletal muscle.多柔比星化疗影响骨骼肌细胞内和细胞间隙的一氧化氮浓度:多柔比星对骨骼肌细胞内和细胞间隙一氧化氮的影响。
Cell Biol Toxicol. 2016 Apr;32(2):121-31. doi: 10.1007/s10565-016-9325-1. Epub 2016 Apr 8.
7
Characterization of the effect of in vivo doxorubicin treatment on skeletal muscle function in the rat.体内阿霉素处理对大鼠骨骼肌功能影响的特征描述。
Anticancer Res. 2011 Jun;31(6):2023-8.
8
Effects of Exercise on Doxorubicin-Induced Skeletal Muscle Dysfunction.运动对阿霉素诱导的骨骼肌功能障碍的影响。
Med Sci Sports Exerc. 2016 Aug;48(8):1468-73. doi: 10.1249/MSS.0000000000000926.
9
Doxorubicin-induced vascular dysfunction and its attenuation by exercise preconditioning.多柔比星诱导的血管功能障碍及其运动预处理的衰减作用。
J Cardiovasc Pharmacol. 2013 Oct;62(4):355-60. doi: 10.1097/FJC.0b013e31829c9993.
10
Multitissue analysis of exercise and metformin on doxorubicin-induced iron dysregulation.多组织分析运动和二甲双胍对多柔比星诱导的铁失调的影响。
Am J Physiol Endocrinol Metab. 2019 May 1;316(5):E922-E930. doi: 10.1152/ajpendo.00140.2018. Epub 2019 Mar 19.

引用本文的文献

1
Doxorubicin-Induced Cardiac Remodeling: Mechanisms and Mitigation Strategies.阿霉素诱导的心脏重塑:机制与缓解策略。
Cardiovasc Drugs Ther. 2025 Feb 26. doi: 10.1007/s10557-025-07673-6.
2
Evaluation of skeletal muscle function in male rats with doxorubicin-induced myopathy following various exercise techniques: the significant role of glucose transporter 4.不同运动技术对阿霉素诱导的雄性大鼠肌病骨骼肌功能的影响:葡萄糖转运蛋白4的重要作用
Pflugers Arch. 2024 May;476(5):797-808. doi: 10.1007/s00424-024-02922-3. Epub 2024 Feb 17.
3
Doxorubicin alters G-protein coupled receptor-mediated vasocontraction in rat coronary arteries.

本文引用的文献

1
Exercise preconditioning modulates genotoxicity induced by doxorubicin in multiple organs of rats.运动预处理调节多柔比星诱导的大鼠多个器官的遗传毒性。
Cell Biochem Funct. 2012 Jun;30(4):293-6. doi: 10.1002/cbf.2799. Epub 2012 Jan 30.
2
Exercise training mitigates anthracycline-induced chronic cardiotoxicity in a juvenile rat model.运动训练可减轻幼年大鼠模型中蒽环类药物引起的慢性心脏毒性。
Pediatr Blood Cancer. 2012 Jul 15;59(1):149-54. doi: 10.1002/pbc.23392. Epub 2011 Nov 2.
3
Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes.
多柔比星改变大鼠冠状动脉中 G 蛋白偶联受体介导的血管收缩。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5831-5845. doi: 10.1007/s00210-024-02988-x. Epub 2024 Feb 8.
4
Creatine and Resistance Training: A Combined Approach to Attenuate Doxorubicin-Induced Cardiotoxicity.肌酸与抗阻训练:减轻阿霉素诱导的心脏毒性的联合方法
Nutrients. 2023 Sep 19;15(18):4048. doi: 10.3390/nu15184048.
5
Endurance exercise training reinforces muscular strength with improvements in mitochondrial oxidative capacity, lysosome reformation, and myogenic differentiation against doxorubicin-induced skeletal muscle wasting in mice.耐力运动训练通过改善线粒体氧化能力、溶酶体重塑以及抗多柔比星诱导的小鼠骨骼肌萎缩的肌源性分化来增强肌肉力量。
Phys Act Nutr. 2023 Mar;27(1):76-86. doi: 10.20463/pan.2023.0010. Epub 2023 Mar 31.
6
Does inflammation markers or treatment type moderate exercise intensity effects on changes in muscle strength in cancer survivors participating in a 6-month combined resistance- and endurance exercise program? Results from the Phys-Can trial.炎症标志物或治疗类型是否会调节参与为期6个月的抗阻与耐力联合运动计划的癌症幸存者的运动强度对肌肉力量变化的影响?来自Phys-Can试验的结果。
BMC Sports Sci Med Rehabil. 2023 Jan 19;15(1):8. doi: 10.1186/s13102-023-00617-3.
7
Effects of High and Low-To-Moderate Intensity Exercise During (Neo-) Adjuvant Chemotherapy on Muscle Cells, Cardiorespiratory Fitness, and Muscle Function in Women With Breast Cancer: Protocol for a Randomized Controlled Trial.(新)辅助化疗期间高强度与低至中等强度运动对乳腺癌女性肌肉细胞、心肺适能和肌肉功能的影响:一项随机对照试验方案
JMIR Res Protoc. 2022 Nov 11;11(11):e40811. doi: 10.2196/40811.
8
Breast cancer survivors with preserved or rescued cardiorespiratory fitness have similar cardiac, pulmonary and muscle function compared to controls.保留或恢复心肺适能的乳腺癌幸存者与对照组相比,具有相似的心脏、肺和肌肉功能。
Eur J Appl Physiol. 2022 Oct;122(10):2189-2200. doi: 10.1007/s00421-022-04992-6. Epub 2022 Jul 7.
9
Chemotherapy induced gastrointestinal toxicities.化疗引起的胃肠道毒性。
Adv Cancer Res. 2022;155:131-166. doi: 10.1016/bs.acr.2022.02.007. Epub 2022 Mar 21.
10
A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J mice.多柔比星与环磷酰胺的临床相关联合治疗不会在C57BL/6J小鼠中诱发肝毒性。
Liver Res. 2021 Dec;5(4):239-242. doi: 10.1016/j.livres.2021.04.002. Epub 2021 May 7.
多柔比星通过线粒体 ROS 刺激 C2C12 肌管中的分解代谢。
Am J Physiol Cell Physiol. 2012 Jan 1;302(1):C195-202. doi: 10.1152/ajpcell.00217.2011. Epub 2011 Sep 21.
4
Epicatechin attenuates doxorubicin-induced brain toxicity: critical role of TNF-α, iNOS and NF-κB.表儿茶素减轻阿霉素诱导的脑毒性:TNF-α、iNOS 和 NF-κB 的关键作用。
Brain Res Bull. 2011 Aug 10;86(1-2):22-8. doi: 10.1016/j.brainresbull.2011.07.001. Epub 2011 Jul 7.
5
Characterization of the effect of in vivo doxorubicin treatment on skeletal muscle function in the rat.体内阿霉素处理对大鼠骨骼肌功能影响的特征描述。
Anticancer Res. 2011 Jun;31(6):2023-8.
6
Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.化疗引起的骨骼肌虚弱和疲劳:氧化应激的作用。
Antioxid Redox Signal. 2011 Nov 1;15(9):2543-63. doi: 10.1089/ars.2011.3965. Epub 2011 Jun 15.
7
Exercise preconditioning provides long-term protection against early chronic doxorubicin cardiotoxicity.运动预处理可提供长期保护,防止早期慢性阿霉素心脏毒性。
Integr Cancer Ther. 2011 Mar;10(1):47-57. doi: 10.1177/1534735410392577. Epub 2011 Mar 7.
8
Exercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle.运动可预防阿霉素诱导的骨骼肌氧化应激和蛋白水解。
J Appl Physiol (1985). 2011 Apr;110(4):935-42. doi: 10.1152/japplphysiol.00677.2010. Epub 2011 Feb 10.
9
Increased efficacy and reduced cardiotoxicity of metronomic treatment with cyclophosphamide in rat breast cancer.环磷酰胺节律性治疗对大鼠乳腺癌疗效的增强及心脏毒性的降低
Anticancer Res. 2011 Jan;31(1):215-20.
10
Effects of endurance training on combined goserelin acetate and doxorubicin treatment-induced cardiac dysfunction.耐力训练对促性腺激素释放激素激动剂联合多柔比星治疗引起的心功能障碍的影响。
Cancer Chemother Pharmacol. 2011 Sep;68(3):685-92. doi: 10.1007/s00280-010-1523-6. Epub 2010 Dec 5.